NCT02339844View on ClinicalTrials.gov

Pan European Collaboration on Antipsychotic Naïve Schizophrenia II

PHASE4CompletedINTERVENTIONAL
Enrollment

130

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

January 31, 2021

Study Completion Date

January 31, 2021

Conditions
Schizophrenia
Interventions
DRUG

Aripiprazole

6 weeks of individual doses of aripiprazole

Trial Locations (1)

2600

Center for Neuropsychiatric Schizophrenia Research, University of Copenhagen, Psychiatric Centre Glostrup, Copenhagen

All Listed Sponsors
lead

University of Copenhagen

OTHER

NCT02339844 - Pan European Collaboration on Antipsychotic Naïve Schizophrenia II | Biotech Hunter | Biotech Hunter